Healthcare Services Group, Inc. (HCSG)
NASDAQ: HCSG · Real-Time Price · USD
15.29
+0.45 (3.00%)
Aug 13, 2025, 4:00 PM - Market closed
Healthcare Services Group Stock Forecast
Stock Price Forecast
According to 4 professional analysts, the 12-month price target for Healthcare Services Group stock ranges from a low of $15 to a high of $19. The average analyst price target of $16.25 forecasts a 6.31% increase in the stock price over the next year.
Price Target: $16.25 (+6.31%)
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Healthcare Services Group stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Mar '25 | Apr '25 | May '25 | Jun '25 | Jul '25 | Aug '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 2 | 2 | 2 | 2 | 2 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 3 | 2 | 2 | 2 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 5 | 5 | 5 | 5 | 4 | 4 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Macquarie | Macquarie | Hold → Buy Upgrades $15 → $16 | Hold → Buy | Upgrades | $15 → $16 | +4.68% | Jul 29, 2025 |
| Benchmark | Benchmark | Strong Buy Maintains $17 → $19 | Strong Buy | Maintains | $17 → $19 | +24.30% | Jul 24, 2025 |
| Baird | Baird | Hold Maintains $13 → $15 | Hold | Maintains | $13 → $15 | -1.86% | Jul 24, 2025 |
| Macquarie | Macquarie | Hold Maintains $15 | Hold | Maintains | $15 | -1.86% | Apr 28, 2025 |
| Baird | Baird | Hold Maintains $12 → $13 | Hold | Maintains | $12 → $13 | -14.95% | Apr 24, 2025 |
Financial Forecast
Revenue This Year
1.86B
from 1.72B
Increased by 8.35%
Revenue Next Year
1.95B
from 1.86B
Increased by 5.00%
EPS This Year
0.86
from 0.53
Increased by 61.78%
EPS Next Year
0.92
from 0.86
Increased by 7.19%
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | 1.9B | 2.0B | 2.1B |
| Avg | 1.9B | 2.0B | 2.1B |
| Low | 1.8B | 1.8B | 2.0B |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | 12.1% | 9.7% | 9.6% |
| Avg | 8.4% | 5.0% | 5.7% |
| Low | 3.0% | -0.8% | 0.8% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | 0.91 | 1.02 | 1.12 |
| Avg | 0.86 | 0.92 | 1.06 |
| Low | 0.78 | 0.78 | 0.99 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | 72.4% | 18.8% | 22.2% |
| Avg | 61.8% | 7.2% | 15.3% |
| Low | 47.9% | -8.6% | 7.5% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.